Exploring GLP-1 Receptor Agonists for Neurodegeneration
Neurology® Podcast
00:00
Exploring GLP-1 Agonists in Neurodegenerative Diseases
This chapter explores the impact of GLP-1 receptor agonists on neurodegenerative diseases like Parkinson's and Alzheimer's. It highlights shared mechanisms like inflammation and protein aggregation, while discussing relevant clinical trials such as the EVOKE trial.
Transcript
Play full episode
